+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Recombinant Cell Culture Supplements Market by Product (Recombinant Albumin, Recombinant Aprotinin, Recombinant Growth Factors), Source (Animals, Human), Application, End-use - Forecast 2024-2030- Product Image
Global Recombinant Cell Culture Supplements Market by Product (Recombinant Albumin, Recombinant Aprotinin, Recombinant Growth Factors), Source (Animals, Human), Application, End-use - Forecast 2024-2030- Product Image
Sale

Global Recombinant Cell Culture Supplements Market by Product (Recombinant Albumin, Recombinant Aprotinin, Recombinant Growth Factors), Source (Animals, Human), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5925193
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Recombinant Cell Culture Supplements Market size was estimated at USD 688.77 million in 2023, USD 784.31 million in 2024, and is expected to grow at a CAGR of 14.37% to reach USD 1,763.46 million by 2030.

Recombinant cell culture supplements are bioengineered products designed to support the growth, proliferation, and maintenance of cells in an artificial environment. These supplements are manufactured through recombinant DNA technology, which involves the insertion of DNA encoding specific proteins or growth factors into host cells, leading to the production of these desired biological elements. Their role is pivotal in optimizing the cell culture conditions necessary for the successful cultivation of mammalian, bacterial, or yeast cells for various applications, including the production of therapeutic proteins and vaccines and for use in tissue engineering and regenerative medicine.

The primary drivers for the recombinant cell culture supplements market include advancements in biotechnology research, rising demand for biopharmaceuticals, and the increasing use of cell culture methods in drug development. Moreover, the rising prevalence of chronic diseases globally boosts the development of novel therapeutics, further propelling market growth. Despite the significant growth potential, the recombinant cell culture supplements market faces challenges, particularly in the form of high production costs and stringent regulatory requirements. However, the expanding field of regenerative medicine and tissue engineering presents considerable opportunities for the recombinant cell culture supplements market. Furthermore, the ongoing research in stem cell therapy and genetic engineering is expected to open new avenues for the application of recombinant cell culture supplements, thereby driving market expansion.

Regional Insights

The Americas region exhibits a robust growth pattern in the recombinant cell culture supplement market owing to its advanced biotechnological research landscape and substantial investments in life sciences. The growing emphasis on regenerative medicine and cell-based therapies particularly propels the demand for high-quality, recombinant supplements. Moreover, the presence of major biopharmaceutical companies and research institutions in this region amplifies market engagement and innovation. The EMEA region displays a diverse market performance characterized by strong growth in Europe, gradually increasing influence in the Middle East and steady advancements in Africa.

The European market benefits from significant research funding, a well-established pharmaceutical industry, and a regulatory environment that supports biotechnological innovations. Meanwhile, the Middle East is witnessing an emerging interest in biopharmaceutical research, fuelled by strategic investments in life sciences. Africa, though still developing in this sector, shows potential for growth with increasing awareness and investment in biotechnology and healthcare infrastructure. Asia-Pacific is projected to exhibit the highest growth rate in the recombinant cell culture supplements market, driven by rapidly growing biotech sectors in countries such as China, Japan, South Korea, and India. The region benefits from improvements in healthcare infrastructure, rising investments in biopharmaceutical R&D, and an increasing number of partnerships and collaborations involving local and international biotech firms.

Market Trends by Segment

  • Product: Increasing utilization of recombinant albumin for the production of vaccines and therapeutic proteins
  • End-use: Ongoing research & development activities academic and research institutes boosts the demand of recombinant cell culture supplements

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

Nucleus Biologics collaborates with Core Biogenesis to revolutionize the availability of Good Manufacturing Practice (GMP) recombinant proteins for the industry. This partnership designates Nucleus Biologics as the GMP manufacturer and distributor of Core Biogenesis' plant-expressed recombinant human proteins, integrating these advanced proteins into Krakatoa pod-based media manufacturing systems by Nucleus Biologics and Stoic Bio.

Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences

Albumedix Ltd and Heartseed Inc. announced a pivotal development in cardiac therapy. Their collaboration has enabled the first human dosing of HS-001, an experimental treatment by Heartseed for advanced heart failure, utilizing Recombumin, a non-animal derived recombinant albumin, as an essential excipient. This partnership underscores Albumedix's commitment to enabling advanced therapeutic innovations, demonstrated by the strategic use of Recombumin to enhance cell viability and support cardiomyocyte sphere formation in HS-001.

Key Company Profiles

The report delves into recent significant developments in the Recombinant Cell Culture Supplements Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Becton, Dickinson and Company, Bio-Techne Corporation, BPS Bioscience, Inc., Cell Sciences, Inc., Cytiva, F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, HiMedia Laboratories Pvt Ltd, InVitria, Kerry Group PLC, Kingfisher Biotech, Inc., Laurus Labs Limited, Lonza Group Ltd., Merck KGaA, Novo Nordisk A/S, Novozymes A/S, PELOBIOTECH GmbH, Repligen Corporation, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., Thermo Fisher Scientific Inc., and Zhuhai Gene-Biocon Biological Technology Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Recombinant Cell Culture Supplements Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing oncology and stem cell research activities globally
5.1.1.2. Supportive government initiatives for biosimilar and biologics products
5.1.2. Restraints
5.1.2.1. High cost associated with recombinant cell culture supplements
5.1.3. Opportunities
5.1.3.1. Rising introduction of novel recombinant cell culture supplements
5.1.3.2. Growing exploration of 3D cell culture technologies
5.1.4. Challenges
5.1.4.1. Incompatibilities of analytical technologies with 3D cell culture
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing utilization of recombinant albumin for the production of vaccines and therapeutic proteins
5.2.2. End-use: Ongoing research & development activities academic and research institutes boosts the demand of recombinant cell culture supplements
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Recombinant Cell Culture Supplements Market, by Product
6.1. Introduction
6.2. Recombinant Albumin
6.3. Recombinant Aprotinin
6.4. Recombinant Growth Factors
6.5. Recombinant Insulin
6.6. Recombinant Lysozyme
6.7. Recombinant Transferrin
6.8. Recombinant Trypsin
7. Recombinant Cell Culture Supplements Market, by Source
7.1. Introduction
7.2. Animals
7.3. Human
8. Recombinant Cell Culture Supplements Market, by Application
8.1. Introduction
8.2. Gene Therapy
8.3. Stem Cell Therapy
8.4. Vaccine Development
9. Recombinant Cell Culture Supplements Market, by End-use
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biopharmaceutical Companies
9.4. Contract Research Centers (CROs)
10. Americas Recombinant Cell Culture Supplements Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Recombinant Cell Culture Supplements Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Recombinant Cell Culture Supplements Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins
13.3.2. Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET DYNAMICS
FIGURE 7. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT APROTININ, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT APROTININ, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT LYSOZYME, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT LYSOZYME, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRANSFERRIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRANSFERRIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRYPSIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY RECOMBINANT TRYPSIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ANIMALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ANIMALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY HUMAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY HUMAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY CONTRACT RESEARCH CENTERS (CROS), BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY CONTRACT RESEARCH CENTERS (CROS), BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 71. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 74. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 75. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 78. CANADA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 79. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 82. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 83. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 86. MEXICO RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 118. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 119. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 122. CHINA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 123. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 126. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 127. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 130. INDIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 139. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 142. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 143. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 146. JAPAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 187. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 190. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 191. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 194. THAILAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 213. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 216. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 217. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 220. DENMARK RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 221. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 224. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 225. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 228. EGYPT RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 229. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 232. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 233. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 236. FINLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 237. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 240. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 241. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 244. FRANCE RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 245. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 246. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 247. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 248. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 249. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 252. GERMANY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 261. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 262. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 263. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 264. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 265. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 268. ITALY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 285. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 288. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 289. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 292. NORWAY RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 293. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 294. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 295. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 296. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 297. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 300. POLAND RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 301. QATAR RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. QATAR RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. QATAR RECOMBINANT CELL CULTURE SUPPL

Companies Mentioned

  • Abcam PLC
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BPS Bioscience, Inc.
  • Cell Sciences, Inc.
  • Cytiva
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Corporation
  • HiMedia Laboratories Pvt Ltd
  • InVitria
  • Kerry Group PLC
  • Kingfisher Biotech, Inc.
  • Laurus Labs Limited
  • Lonza Group Ltd.
  • Merck KGaA
  • Novo Nordisk A/S
  • Novozymes A/S
  • PELOBIOTECH GmbH
  • Repligen Corporation
  • Sartorius AG
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Zhuhai Gene-Biocon Biological Technology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 784.31 Million
Forecasted Market Value ( USD ) by 2030 $ 1763.46 Million
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Recombinant Cell Culture Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Recombinant Cell Culture Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 309 Pages
  • Global
Global Recombinant Cell Culture Supplements Market Report and Forecast 2023-2031 - Product Image

Global Recombinant Cell Culture Supplements Market Report and Forecast 2023-2031

  • Report
  • 140 Pages
  • Global
From
Global Cell Culture Reagents Market by Product (Antibiotic, Buffer, Cryoprotective), Application (Bioproduction, Diagnostics, Research), End-User - Forecast 2024-2030 - Product Image

Global Cell Culture Reagents Market by Product (Antibiotic, Buffer, Cryoprotective), Application (Bioproduction, Diagnostics, Research), End-User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Logistics & Distribution, Storage & Retention), By Separation Method, By Cell Type, By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Logistics & Distribution, Storage & Retention), By Separation Method, By Cell Type, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Copyright © 2002-2024 Research and Markets. All Rights Reserved.